Pharmaceuticals (16) | Investment Agreements (16)

Browse by Company

Recent Contracts

Amending Agreement to Transaction Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO (Tilray, Inc., Filed With SEC on June 14, 2022)
Amended and Restated Assignment and Assumption Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO (Tilray, Inc., Filed With SEC on June 14, 2022)
Transaction Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp (Tilray, Inc., Filed With SEC on April 12, 2022)
Assignment and Assumption Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp (Tilray, Inc., Filed With SEC on April 12, 2022)
Investment agreement with SciSparc Ltd. dated March 1, 2021 (TAURIGA SCIENCES, INC., Filed With SEC on June 29, 2021)
Equity Commitment and Investment Agreement dated March 8, 2021 by and between ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited Partnership (ANI Pharma Inc, Filed With SEC on March 9, 2021)
Investment Banking Agreement (WEED, INC., Filed With SEC on March 8, 2021)
Amendment to Investment Agreement, dated November 18, 2020 (TAURIGA SCIENCES, INC., Filed With SEC on November 19, 2020)
Letter Agreement, dated June 30, 2020, among the Company, the Sponsor, Cowen Investments and the Companys officers and directors (Panacea Acquisition Corp, Filed With SEC on July 6, 2020)
Form of Letter Agreement among the Registrant and the Registrants officers and directors, EcoR1 Panacea Holdings, LLC and Cowen Investments II LLC (Panacea Acquisition Corp, Filed With SEC on June 23, 2020)